Merit Medical Systems Inc MMSI
Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. 10-K, Item 1
- Employees
- 7,500
- Headquarters
- South Jordan, UT
- Next results
- around Jan 7, 2027
Where each dollar of revenue went, FY2025
Revenue of $1.5B through the costs to a net profit of $128.5M · income statement of the 10-K
MMSI among Health care peers
Six ratios from the latest 10-K. Each corner is the share of 154 peers the company is above, not a score.
What changed
12 new risk paragraphs. 10-K filed Feb 24, 2026 against Feb 25, 2025.
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
Accounting checks
11 checks on the latest 10-K. Checks, not verdicts.
0facts worth reading about all 11 checks found nothing to note
-
Receivables +7.1% ($190.2M to $203.7M) vs revenue +11.8% ($1.4B to $1.5B), -4.7 pts apart
-
Cash from operations $297.4M vs net income $128.5M (FY ending Dec 31, 2025)
-
Inventory +9.0% ($306.1M to $333.7M) vs revenue +11.8% ($1.4B to $1.5B), -2.7 pts apart
8 more checks with nothing to note
-
Same auditor in both 10-Ks: DELOITTE & TOUCHE LLP
-
No statement of substantial doubt about going concern
-
No 8-K item 4.02 in the last 2 years
-
No NT 10-K or NT 10-Q in the last 2 years
-
The same matters as last year: Inventories - Provision for estimated excess, slow moving and obsolete inventories; Intangible Assets - Biolife Developed Technology
-
No sentence in the 10-K concludes that controls were not effective because of a material weakness
-
No 8-K item 2.06 in the last 2 years
-
No 8-K item 1.03 in the last 2 years
In their words
12 paragraphs in Risk Factors that were not in the 10-K filed Feb 25, 2025. Quoted as filed.
-
Item 1A · new paragraph · not in the 10-K filed Feb 25, 2025 10-K, ITEM 1A
Furthermore, tariffs or other trade restrictions may lead to continuing uncertainty and volatility in U.S. and global financial and economic conditions and commodity markets, significant inflation, and reduced demand for our products. Also, disruptions and volatility in the financial markets may lead to adverse changes in the…
-
Item 1A · new paragraph · not in the 10-K filed Feb 25, 2025 10-K, ITEM 1A
Furthermore, we may find limited demand for otherwise promising new products unless reimbursement approval is obtained from private and governmental third-party payers. Legislative or administrative reforms to the reimbursement systems in the U.S., Japan, China, or other countries in a manner that significantly reduces or eliminates…
-
Item 1A · new paragraph · not in the 10-K filed Feb 25, 2025 10-K, ITEM 1A
The development, deployment and use of AI in our business operations could result in regulatory action, legal liability, operational challenges or reputational harm and our failure to adapt to developments related to AI in a timely manner (or at all) could adversely affect our business, financial condition or results of operations. We…
-
Item 1A · new paragraph · not in the 10-K filed Feb 25, 2025 10-K, ITEM 1A
Effective October 3, 2025, Fred Lampropoulos resigned as Chief Executive Officer and President of Merit and Merit’s Board of Directors appointed Martha G. Aronson as a Director and as Merit’s new Chief Executive Officer and President. Additionally, effective January 4, 2026, Mr. Lampropoulos resigned as a Director and Chair of the Board…
New risk paragraphs, against peers
Latest 10-K of each, Health care companies closest in revenue
Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.
Financial performance
Last 4 fiscal years · 10-K XBRL
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $1.2B | $1.3B | $1.4B | $1.5B |
| Net income | $74.5M | $94.4M | $120.4M | $128.5M |
| Operating cash flow | $114.3M | $145.2M | $220.8M | $297.4M |
| Free cash flow | $69.3M | $110.9M | $185.7M | $215.7M |
Revenue, FY2016 to FY2025
Ten fiscal years, each from its own 10-K · XBRL · USD
$1.5B ▲ 11.8% in FY2025$128.5M ▲ 6.8% in FY2025$215.7M ▲ 16.2% in FY2025
Recent filings
4 filings in the last 30 days · SEC EDGAR
-
SEC letterNov 14, 2026SEC asked 2 questions about Form 10-K for the Fiscal Year Ended December 31, 2017 letters Mar 29, 2018 to Apr 20, 2018 · Russia and Ukraine, Revenue
-
Planned saleOct 29, 2026Michel Voigt (Chief Human Resources Officer) adopted a 10b5-1 trading plan reported in the 10-Q, up to 7,682 shares, runs to May 12, 2027
-
8-KOct 29, 2026Quarterly results, Regulation FD disclosure 8-K items 2.02, 7.01
-
10-QOct 29, 2026Quarterly report (10-Q) period ended Sep 30, 2026
About the company
Merit Medical Systems Inc, South Jordan, UT · from the 10-K filed Feb 24, 2026
Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. We strive to be the most customer-focused company in healthcare. Each day we are determined to make a difference by understanding our customers’ needs and innovating and delivering a diverse range of products that improve the lives of people and communities throughout the world.
- Headquarters
- South Jordan, UT
- Country
- United States
- Reports in
- USD
- Listed on
- Nasdaq
- Fiscal year ends
- December 31
- Last results
- Oct 29, 2026
- Incorporated in
- UT
Employees, at the top of the page: "As of December 31, 2025, we had approximately 7,500 employees located in approximately 43 countries performing a variety of roles" (10-K). Address and exchange: SEC's company file.
Email alerts
Sources
The 10-K filed Feb 24, 2026 (open at SEC), compared with the 10-K filed Feb 25, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.
Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MMSI/export.csv") into a cell.